Preference for nonsteroidal antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis

Journal of Rheumatology

Volumn 27, Issue 4, 2000, Pages 1020-1027

  Pincus, Theodore ^a   Swearingen, Christopher ^b   Cummins, Patricia ^b   Callahan, Leigh F ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Acetaminophen; Nonsteroidal antiinflammatory drug; Osteoarthritis; Survey

Indexed keywords

DICLOFENAC; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; AGED; ARTICLE; DRUG EFFICACY; DRUG PREFERENCE; DRUG TOLERABILITY; DRUG USE; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL;

ACETAMINOPHEN; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DATA COLLECTION; DICLOFENAC; FEMALE; HUMANS; IBUPROFEN; MALE; NAPROXEN; OSTEOARTHRITIS; PATIENT SATISFACTION; QUESTIONNAIRES; SELF ADMINISTRATION;

EID: 0034120920     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Lawrence RC, Hochberg MC, Kelsey JL, et al. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989;16:427-41.
2. Hochberg MC. Epidemiologic considerations in the primary prevention of osteoarthritis [editorial]. J Rheumatol 1991; 18:1438-40.
3. Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988;109:359-63.
4. Fries JF, Williams CA, Bloch DA, Michel BA. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med 1991;91:213-22.
5. Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, Bloch DA. Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. Gastroenterology 1989;96:647-55.
6. Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, Bloch DA. Identification of patients at risk for gastropathy associated with NSAID use. J Rheumatol 1990;17 Suppl 20:12-9.
7. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs. Ann Intern Med 1991;115:787-96.
8. Caldwell JR, Roth SH, Wu WC, et al. Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage. Am J Med 1987;83 Suppl 3B: 74-82.
9. Graham DY, Agrawal NM, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 1988;2:1277-80.
10. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123:241-9.
11. Ehsanullah RSB, Page MC, Tildesley G, Wood JR. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ 1988;297:1017-21.
12. Oddsson E, Gudjonsson H, Thjodleifsson B. Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen. Scand J Gastroenterol 1992; 27:1045-8.
13. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998;338:727-34.
14. Yeomans ND, Tulassay Z, Juhasz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998;338:719-26.
15. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of an antiinflammatory dose of ibuprofen, and analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991; 325:87-91.
16. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nunsteroidal antiinflammatory drug or pure analgesic. J Rheumatol 1992;19:1950-4.
17. Griffin MR, Brandt KD, Liang MH, Pincus T, Ray WA. Practical management of osteoarthritis: integration of pharmacologic and nonpharmacologic measures. Arch Fam Med 1995;4:1049-55.
18. Hawkey CJ. COX-2 inhibitors. Lancet 1999;353:307-14.
19. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. Arthritis Rheum 1995;38:1535-40.
20. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for medical management of osteoarthritis. Part II. Osteoarthritis of the knee. Arthritis Rheum 1995;38:1541-6.
21. Feinstein AR. An additional basic science for clinical medicine: II. The limitations of randomized trials. Ann Intern Med 1983; 99:544-50.
22. Freireich EJ. The randomized clinical trial as an obstacle to clinical research. In: Varco RL, Delaney JP, editors. Controversy in surgery. 2nd ed. Philadelphia: Saunders; 1983:5-12.
23. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med 1996;125:605-13.
24. Pincus T. Rheumatoid arthritis: Disappointing long-term outcomes despite successful short-term clinical trials. J Clin Epidemiol 1988;41:1037-41.
25. Pincus T. The paradox of effective therapies but poor long-term outcomes in rheumatoid arthritis. Semin Arthritis Rheum 1992;21:2-15.
26. Pincus T, Stein M. What is the best source of useful data on the treatment of rheumatoid arthritis: clinical trials, clinical observations, or clinical protocols? J Rheumatol 1995;22:1611-7.
27. Pincus T, Stein CM. Why randomized controlled clinical trials do not depict accurately long-term outcomes in rheumatoid arthritis: some explanations and suggestions for future studies. Clin Exp Rheumatol 1997;15Suppl 17:S27-S38.
28. Wasner C, Britton MC, Kraines RG, Kaye RL, Bobrove AM, Fries JF. Nonsteroidal anti-inflammatory agents in rheumatoid arthritis and ankylosing spondylitis. JAMA 1981;246:2168-72.
29. Gall ER, Caperton EM, McComb JE, et al. Clinical comparison of ibuprofen, fenoprofen calcium, naproxen and tolmetin sodium in rheumatoid arthritis. J Rheumatol 1982;9:402-7.
30. Isomaki H, Martio J, Kaarela K, et al. Comparison of the analgesic effect often nonsteroidal anti-inflammatory drugs. Br J Rheumatol 1984;23:61-5.
31. Pincus T, Marcum SB, Callahan LF, et al. Long-term drug therapy for rheumatoid arthritis in seven rheumatology private practices: I. Nonsteroidal anti-inflammatory drugs. J Rheumatol 1992; 19:1874-84.
32. Scholes D, Stergachis A, Penna PM, Normand EH, Hansten PD. Nonsteroidal antiinflammatory drug discontinuation in patients with osteoarthritis. J Rheumatol 1995;22:708-12.
33. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864-72.
34. Pincus T, Callahan LF. Clinical use of multiple nonsteroidal antiinflammatory drug preparations within individual rheumatology private practices. J Rheumatol 1989;16:1253-8.
35. Wolfe F, Pincus T. Data collection in the clinic. Rheum Dis Clin North Am 1995;21:321-58.
36. Pincus T. Documenting quality management in rheumatic disease: Are patient questionnaires the best (and only) method? Arthritis Care Res 1996;9:339-48.